Who Paid My Doc
Intellis Adaptivestim
Device Spinal Cord Neurostimulation
PDI 00643169781702
General payments
$12,070,152
Research payments
$2,589,079
Through program year 2025, $12,070,152 in general payments and $2,589,079 in research payments were reported against Intellis Adaptivestim (Spinal Cord Neurostimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,231,524 | 19,609 |
| 2025 | Research | $10,552 | 3 |
| 2024 | General | $4,001,027 | 43,127 |
| 2024 | Research | $430,861 | 113 |
| 2023 | General | $3,147,595 | 38,683 |
| 2023 | Research | $1,376,839 | 153 |
| 2022 | General | $2,690,007 | 28,832 |
| 2022 | Research | $770,827 | 159 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 125 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
130,251 general · 428 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.